Drug Repurposing Screen Reveals FDA-Approved Inhibitors of Human HMG-CoA Reductase and Isoprenoid Synthesis That Block Cryptosporidium Parvum Growth

Antimicrobial Agents and Chemotherapy - United States
doi 10.1128/aac.02460-12
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society for Microbiology

Related search

Pleiotropic Effects of the HMG-CoA Reductase Inhibitors

International Journal of General Medicine
Medicine
2011English

HMG CoA Reductase Inhibitors (Statins) for Dialysis Patients

2009English

Inflammation, Immunity, and HMG-CoA Reductase Inhibitors: Statins as Antiinflammatory Agents?

Circulation
Cardiovascular MedicinePhysiologyCardiology
2004English

Exploration of Virtual Candidates for Human HMG-CoA Reductase Inhibitors Using Pharmacophore Modeling and Molecular Dynamics Simulations

PLoS ONE
Multidisciplinary
2013English

HMG-CoA Reductase Inhibitors and the Risk of Hip Fractures in Elderly Patients

JAMA - Journal of the American Medical Association
Medicine
2000English

Repurposing FDA-approved Drugs for Anti-Aging Therapies

Biogerontology
AgingGerontologyGeriatrics
2016English

Cholesterol, C-Reactive Protein, and Periodontitis: HMG-CoA-Reductase Inhibitors (Statins) as Effect Modifiers

ISRN Dentistry
2011English

Role of HMG-CoA Reductase Inhibitors With Curative Radiotherapy in Men With Prostate Cancer

Research and Reports in Urology
Urology
2011English

Feedback Regulation of Cholesterol Synthesis: Sterol-Accelerated Ubiquitination and Degradation of HMG CoA Reductase

Cell Research
Cell BiologyMolecular Biology
2008English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy